Nedometinib (NFX-179) is a selective mitogen-activated protein kinase kinase (MEK1) inhibitor with anticancer and antitumor activity, inhibits MAPK pathway signaling in the skin, inhibits the growth of human squamous cell lines in a dose-dependent manner, and can be used to study malignant tumors.
Molekulargewicht:
470.24
Reinheit:
99.18%
CAS Nummer:
[2252314-46-6]
Formel:
C17H16FIN4O3
Target-Kategorie:
MEK|||p38 MAPK|||PERK
T78209
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten